Amgen (NASDAQ: AMGN) recently released clinical results for its developmental weight loss drug MariTide. Shares fell by as ...
Rep. Brad Wenstrup, R-Ohio, said his bill on the topic creates a more holistic approach than simple government coverage by ...
Eli Lilly and Company announced a significant expansion at its Pleasant Prairie facility Thursday. The pharmaceutical giant plans a $3 billion investment, which is expected to create 750 new jobs at ...
It appears not all weight-loss drugs are created equal. The users of one drug report more weight loss comparted to another ...
DealBook Summit, Lilly CEO David Ricks said GLP-1 drugs have the potential to treat more than obesity — including heart disease and substance use disorders.
Department of Veterans Affairs leaders request billions of dollars in additional funding as House lawmakers slam them for ...
(Reuters) - Eli Lilly said on Thursday it will invest $3 billion to expand the manufacturing plant it bought in Pleasant ...
Eli Lilly & Co. is spending another $3 billion to build out its US manufacturing footprint as it ramps up production of its ...
Data suggests that dramatic weight loss, including via GLP-1 drugs, could save Americans big bucks in healthcare spending.
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Some people are taking tiny amounts of weight loss medications, hoping to drop pounds while avoiding side effects. Does it ...